FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285594345> ?p ?o ?g. }

• W4285594345 endingPage "4515" @default.
• W4285594345 startingPage "4515" @default.
• W4285594345 abstract "Influenza virus infections continue to be a significant and recurrent public health problem. Although vaccine efficacy varies, regular immunisation is the most effective method for suppressing the influenza virus. Antiviral drugs are available for influenza, although two of the four FDA-approved antiviral treatments have resulted in significant drug resistance. Therefore, new treatments are being sought to reduce the burden of flu-related illness. The time-consuming development of treatments for new and re-emerging diseases such as influenza and the high failure rate are increasing concerns. In this context, we used an in silico-based drug repurposing method to repurpose FDA-approved drugs as potential therapies against the H7N9 virus. To find potential inhibitors, a total of 2568 drugs were screened. Promacta, tucatinib, and lurasidone were identified as promising hits in the DrugBank database. According to the calculations of MM-GBSA, tucatinib (-54.11 kcal/mol) and Promacta (-56.20 kcal/mol) occupied the active site of neuraminidase with a higher binding affinity than the standard drug peramivir (-49.09 kcal/mol). Molecular dynamics (MD) simulation studies showed that the C-α atom backbones of the complexes of tucatinib and Promacta neuraminidase were stable throughout the simulation period. According to ADME analysis, the hit compounds have a high gastrointestinal absorption (GI) and do not exhibit properties that allow them to cross the blood-brain barrier (BBB). According to the in silico toxicity prediction, Promacta is not cardiotoxic, while lurasidone and tucatinib show only weak inhibition. Therefore, we propose to test these compounds experimentally against the influenza H7N9 virus. The investigation and validation of these potential H7N9 inhibitors would be beneficial in order to bring these compounds into clinical settings." @default.
• W4285594345 created "2022-07-16" @default.
• W4285594345 creator A5005397606 @default.
• W4285594345 creator A5041854618 @default.
• W4285594345 date "2022-07-15" @default.
• W4285594345 modified "2023-09-30" @default.
• W4285594345 title "In Silico Drug Repurposing of FDA-Approved Drugs Highlighting Promacta as a Potential Inhibitor of H7N9 Influenza Virus" @default.
• W4285594345 cites W1549357029 @default.
• W4285594345 cites W186059533 @default.
• W4285594345 cites W1975580333 @default.
• W4285594345 cites W1988044361 @default.
• W4285594345 cites W1995452398 @default.
• W4285594345 cites W1996719014 @default.
• W4285594345 cites W2004396083 @default.
• W4285594345 cites W2005855529 @default.
• W4285594345 cites W2032222317 @default.
• W4285594345 cites W2045859246 @default.
• W4285594345 cites W2047163848 @default.
• W4285594345 cites W2073616175 @default.
• W4285594345 cites W2075424853 @default.
• W4285594345 cites W2077753444 @default.
• W4285594345 cites W2080983071 @default.
• W4285594345 cites W2092528857 @default.
• W4285594345 cites W2093762900 @default.
• W4285594345 cites W2105668062 @default.
• W4285594345 cites W2106173155 @default.
• W4285594345 cites W2134967712 @default.
• W4285594345 cites W2135732933 @default.
• W4285594345 cites W2137727873 @default.
• W4285594345 cites W2142868265 @default.
• W4285594345 cites W2148893085 @default.
• W4285594345 cites W2159340685 @default.
• W4285594345 cites W2160305962 @default.
• W4285594345 cites W2169678694 @default.
• W4285594345 cites W2562144938 @default.
• W4285594345 cites W2585278629 @default.
• W4285594345 cites W2593436234 @default.
• W4285594345 cites W2605082299 @default.
• W4285594345 cites W2767891136 @default.
• W4285594345 cites W2782037384 @default.
• W4285594345 cites W2801088198 @default.
• W4285594345 cites W2894555242 @default.
• W4285594345 cites W2948831670 @default.
• W4285594345 cites W2954297401 @default.
• W4285594345 cites W3009999522 @default.
• W4285594345 cites W3023126697 @default.
• W4285594345 cites W3029944349 @default.
• W4285594345 cites W3086563090 @default.
• W4285594345 cites W3121562227 @default.
• W4285594345 cites W3128592400 @default.
• W4285594345 cites W3128905596 @default.
• W4285594345 cites W3133931646 @default.
• W4285594345 cites W3155612481 @default.
• W4285594345 cites W3184487387 @default.
• W4285594345 cites W3214679520 @default.
• W4285594345 doi "https://doi.org/10.3390/molecules27144515" @default.
• W4285594345 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35889388" @default.
• W4285594345 hasPublicationYear "2022" @default.
• W4285594345 type Work @default.
• W4285594345 citedByCount "3" @default.
• W4285594345 countsByYear W42855943452022 @default.
• W4285594345 countsByYear W42855943452023 @default.
• W4285594345 crossrefType "journal-article" @default.
• W4285594345 hasAuthorship W4285594345A5005397606 @default.
• W4285594345 hasAuthorship W4285594345A5041854618 @default.
• W4285594345 hasBestOaLocation W42855943451 @default.
• W4285594345 hasConcept C103637391 @default.
• W4285594345 hasConcept C104317684 @default.
• W4285594345 hasConcept C126322002 @default.
• W4285594345 hasConcept C134164806 @default.
• W4285594345 hasConcept C151730666 @default.
• W4285594345 hasConcept C155261790 @default.
• W4285594345 hasConcept C159047783 @default.
• W4285594345 hasConcept C185592680 @default.
• W4285594345 hasConcept C18903297 @default.
• W4285594345 hasConcept C2522874641 @default.
• W4285594345 hasConcept C2775905019 @default.
• W4285594345 hasConcept C2777538117 @default.
• W4285594345 hasConcept C2779134260 @default.
• W4285594345 hasConcept C2779343474 @default.
• W4285594345 hasConcept C2780035454 @default.
• W4285594345 hasConcept C3008058167 @default.
• W4285594345 hasConcept C519536355 @default.
• W4285594345 hasConcept C524204448 @default.
• W4285594345 hasConcept C55493867 @default.
• W4285594345 hasConcept C71924100 @default.
• W4285594345 hasConcept C86803240 @default.
• W4285594345 hasConcept C98274493 @default.
• W4285594345 hasConceptScore W4285594345C103637391 @default.
• W4285594345 hasConceptScore W4285594345C104317684 @default.
• W4285594345 hasConceptScore W4285594345C126322002 @default.
• W4285594345 hasConceptScore W4285594345C134164806 @default.
• W4285594345 hasConceptScore W4285594345C151730666 @default.
• W4285594345 hasConceptScore W4285594345C155261790 @default.
• W4285594345 hasConceptScore W4285594345C159047783 @default.
• W4285594345 hasConceptScore W4285594345C185592680 @default.
• W4285594345 hasConceptScore W4285594345C18903297 @default.
• W4285594345 hasConceptScore W4285594345C2522874641 @default.

• next